We are live on ! Find out more
LA

Linden Advisors Portfolio holdings

AUM $17.9B
1-Year Est. Return 1.72%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+1.72%
3 Year Est. Return
+2.79%
5 Year Est. Return
+3.4%
10 Year Est. Return
+25.58%
AUM
$10.9B
AUM Growth
+$52.3M
Cap. Flow
-$9.18B
Cap. Flow %
-83.91%
Top 10 Hldgs %
33.86%
Holding
741
New
12
Increased
1
Reduced
19
Closed
46
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRU
301
DELISTED
Crucible Acquisition Corporation
CRU
$419K ﹤0.01%
42,107
ESLA icon
302
Estrella Immunopharma
ESLA
$32.2M
$418K ﹤0.01%
41,538
MVLA
303
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$417K ﹤0.01%
41,945
ORIA
304
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$411K ﹤0.01%
41,814
LGAC
305
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$407K ﹤0.01%
41,009
GTPB
306
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
$404K ﹤0.01%
41,187
NFYS
307
DELISTED
Enphys Acquisition Corp.
NFYS
$400K ﹤0.01%
41,087
AVPTW
308
DELISTED
AvePoint Inc Warrant
AVPTW
$398K ﹤0.01%
641,344
BIOT
309
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$396K ﹤0.01%
40,008
-638,841
-94% -$6.31M
TMAC
310
DELISTED
The Music Acquisition Corporation
TMAC
$392K ﹤0.01%
39,762
CHEA
311
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
$373K ﹤0.01%
+36,904
New +$370K
FVT
312
DELISTED
Fortress Value Acquisition Corp. III
FVT
$371K ﹤0.01%
37,453
SANB
313
DELISTED
Sanaby Health Acquisition Corp. I Class A Common Stock
SANB
$370K ﹤0.01%
36,558
-591,929
-94% -$5.98M
AEON icon
314
AEON Biopharma
AEON
$11.2M
$368K ﹤0.01%
518
AGILW
315
DELISTED
AgileThought Inc Warrant
AGILW
$365K ﹤0.01%
868,886
DTI icon
316
Drilling Tools International
DTI
$79.4M
$355K ﹤0.01%
35,515
VAQC
317
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$343K ﹤0.01%
34,645
CLINR
318
DELISTED
Clean Earth Acquisitions Corp. Right
CLINR
$330K ﹤0.01%
1,500,000
CERO
319
DELISTED
CERo Therapeutics
CERO
$325K ﹤0.01%
16
-234
-94% -$4.71M
GFX
320
DELISTED
Golden Falcon Acquisition Corp.
GFX
$324K ﹤0.01%
32,586
SVNA
321
DELISTED
7 Acquisition Corp
SVNA
$324K ﹤0.01%
32,094
TBCP
322
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$306K ﹤0.01%
31,103
-468,897
-94% -$4.61M
NRAC
323
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$293K ﹤0.01%
29,548
-445,452
-94% -$4.4M
GIACW
324
DELISTED
Gesher I Acquisition Corp. Warrants
GIACW
$285K ﹤0.01%
487,500
LOKM
325
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$278K ﹤0.01%
28,306
-489,678
-95% -$4.82M

Similar funds

Linden Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Linden Advisors held 741 positions worth $10.9B, up 0.48% from $10.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Linden Advisors withdrew a net $9.18B in Q3 2022, closing 46 positions and reducing 19 holdings. Its most notable exit was IG Acquisition Corp. Class A Common Stock, an estimated $26.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 12% a quarter earlier, followed by Technology and Industrials.

Against the trend, Linden Advisors opened a new position in Wayfair worth $3.79M.

  • Linden Advisors's largest Q3 2022 buy was Wayfair: 116,523 shares worth $3.79M.
  • Linden Advisors added most to Revelation Biosciences Warrant in Q3 2022, an estimated $30.7K increase.
  • Linden Advisors's biggest Q3 2022 reduction was North Atlantic Acquisition Corporation Class A Ordinary Share, cutting an estimated $13M.
  • Linden Advisors fully exited IG Acquisition Corp. Class A Common Stock in Q3 2022, selling an estimated $26.4M.
  • Linden Advisors's ten largest holdings make up 34% of its $10.9B portfolio in Q3 2022.
  • Linden Advisors opened 12 new positions and closed 46 in Q3 2022.
  • Linden Advisors's portfolio value rose 0.48% quarter-over-quarter to $10.9B.

Based on Linden Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.